{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:30:14Z","timestamp":1783643414349,"version":"3.55.0"},"reference-count":152,"publisher":"Elsevier","isbn-type":[{"value":"9780128047958","type":"print"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1016\/bs.apcsb.2015.09.007","type":"book-chapter","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T21:52:33Z","timestamp":1446673953000},"page":"1-39","source":"Crossref","is-referenced-by-count":30,"title":["High-Performance Affinity Chromatography"],"prefix":"10.1016","author":[{"given":"Zhao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandya R.","family":"Beeram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Suresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiwei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/bs.apcsb.2015.09.007_bb0005","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/bmc.3238","article-title":"Binding of caffeic acid to human serum albumin by the retention data and frontal analysis","volume":"28","author":"An","year":"2014","journal-title":"Biomedical Chromatography"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/2213235X1130100005","article-title":"Effects of fatty acids and glycation on drug interactions with human serum albumin","volume":"1","author":"Anguizola","year":"2013","journal-title":"Current Metabolomics"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0015","doi-asserted-by":"crossref","first-page":"4453","DOI":"10.1021\/ac303734c","article-title":"Development of affinity microcolumns for drug-protein binding studies in personalized medicine: Interactions of sulfonylurea drugs with in vivo glycated human serum albumin","volume":"85","author":"Anguizola","year":"2013","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0020","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.cca.2013.07.013","article-title":"Review: Glycation of human serum albumin","volume":"425","author":"Anguizola","year":"2013","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0025","series-title":"Blood lipids and lipoproteins: Quantitation, composition, and metabolism","first-page":"587","article-title":"Lipoprotein class distribution in normal and disease states","author":"Barklay","year":"1972"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0030","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.cca.2010.04.007","article-title":"Quantitative analysis of glycation sites on human serum albumin using 16O\/18O-labeling and matrix-assisted laser desorption\/ionization time-of-flight mass spectrometry","volume":"411","author":"Barnaby","year":"2010","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/092986607779117191","article-title":"Spectroscopic studies of the effects of glycation of human serum albumin on L-Trp binding","volume":"14","author":"Barzegar","year":"2007","journal-title":"Protein and Peptide Letters"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0040","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1016\/j.jchromb.2010.09.033","article-title":"Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids","volume":"878","author":"Basiaga","year":"2010","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0045","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0378-1119(86)90051-X","article-title":"Molecular cloning and nucleotide sequence of human alpha1 acid glycoprotein cDNA","volume":"44","author":"Board","year":"1986","journal-title":"Gene"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0050","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3109\/00365517209084298","article-title":"The effect of antimicrobial agents on bilirubin binding by human erythrocytes","volume":"30","author":"Bratlid","year":"1972","journal-title":"Scandinavian Journal of Clinical and Laboratory Investigation"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0055","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11894-011-0220-x","article-title":"Update on the management of Crohn's disease","volume":"13","author":"Buchner","year":"2011","journal-title":"Current Gastroenterology Reports"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0060","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jssc.200401827","article-title":"Applications of silica-based monolithic HPLC columns","volume":"27","author":"Cabrera","year":"2004","journal-title":"Journal of Separation Science"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0065","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jpba.2010.11.040","article-title":"Frontal affinity chromatography in characterizing immobilized receptors","volume":"54","author":"Calleri","year":"2011","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0070","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138920307779941497","article-title":"The acute phase protein \u03b11-acid glycoprotein: A model for altered glycosylation during diseases","volume":"8","author":"Ceciliani","year":"2007","journal-title":"Current Protein and Peptide Science"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0378-4347(98)00140-6","article-title":"Development of tryptophan-modified human serum albumin columns for site-specific studies of drug-protein interactions by high-performance affinity chromatography","volume":"715","author":"Chattopadhyay","year":"1998","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0080","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/chir.20216","article-title":"Chromatographic analysis of allosteric effects between ibuprofen and benzodiazepines on human serum albumin","volume":"18","author":"Chen","year":"2006","journal-title":"Chirality"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0085","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1038\/nbt1022","article-title":"Quantitative analysis of allosteric drug-protein binding by biointeraction chromatography","volume":"22","author":"Chen","year":"2004","journal-title":"Nature Biotechnology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0090","series-title":"Handbook of affinity chromatography","article-title":"Quantitative affinity chromatography: practical aspects","author":"Chen","year":"2006"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0095","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1021\/ac052017b","article-title":"Quantitative studies of allosteric effects by biointeraction chromatography: Analysis of protein binding to low solubility drugs","volume":"78","author":"Chen","year":"2006","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0100","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jchromb.2004.06.012","article-title":"Studies of phenytoin binding to human serum albumin by high-performance affinity chromatography","volume":"809","author":"Chen","year":"2004","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0105","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/jssc.200900074","article-title":"Noncompetitive peak decay analysis of drug-protein dissociation by high-performance affinity chromatography","volume":"32","author":"Chen","year":"2009","journal-title":"Journal of Separation Science"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0110","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ab.2009.10.017","article-title":"Analysis of drug interactions with high-density lipoprotein by high-performance affinity chromatography","volume":"397","author":"Chen","year":"2010","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0115","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0021-9673(00)00548-3","article-title":"Antibody immobilization to high-performance liquid chromatographic supports: Characterization of maximum loading capacity for intact immunoglobulin G and Fab fragments","volume":"888","author":"Clarke","year":"2000","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0120","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1021\/ac0009752","article-title":"Analysis of free drug fractions by ultra-fast immunoaffinity chromatography","volume":"73","author":"Clarke","year":"2001","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0125","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1021\/ac000870z","article-title":"Development of sandwich HPLC microcolumns for analyte adsorption on the millisecond time scale","volume":"73","author":"Clarke","year":"2001","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0130","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1021\/ac040127x","article-title":"Analysis of free hormone fractions by an ultrafast immunoextraction\/displacement immunoassay: Studies using free thyroxine as a model system","volume":"77","author":"Clarke","year":"2005","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0135","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1517\/13543784.2010.510513","article-title":"Investigational agents for Crohn's disease","volume":"19","author":"Cottone","year":"2010","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jchromb.2012.02.036","article-title":"Evaluation of human interferon adsorption performance of Cibacron Blue F3GA attached cryogels and interferon purification by using FPLC system","volume":"893\u2013894","author":"Dogan","year":"2012","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0145","series-title":"Lipoproteins and lipids","first-page":"255","article-title":"Hyperlipidemia: diagnosis and management","author":"Durrington","year":"1989"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: From bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Molecular Aspects of Medicine"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0155","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0167-4838(00)00153-9","article-title":"Alpha-1-acid glycoprotein","volume":"1482","author":"Founier","year":"2000","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0160","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1016\/S0021-9258(17)34729-4","article-title":"Kinetics and mechanism of bilirubin binding to human serum albumin","volume":"253","author":"Gary","year":"1978","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0165","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0170","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.trsl.2009.09.005","article-title":"Genomic and personalized medicine: Foundations and applications","volume":"154","author":"Gunsburg","year":"2009","journal-title":"Translational Research"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0175","series-title":"Handbook of affinity chromatography","article-title":"Support materials for affinity chromatography","author":"Gustavsson","year":"2006"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0180","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0021-9673(00)00957-2","article-title":"Chromatographic and electrophoretic studies of protein binding to chiral solutes","volume":"906","author":"Hage","year":"2001","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-4347(01)00482-0","article-title":"High-performance affinity chromatography: A powerful tool for studying serum protein binding","volume":"768","author":"Hage","year":"2002","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/138920011795202938","article-title":"Characterization of drug interactions with serum proteins by using high-performance affinity chromatography","volume":"12","author":"Hage","year":"2011","journal-title":"Current Drug Metabolism"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1039\/c1ay05068k","article-title":"Chromatographic analysis of drug interactions in the serum proteome","volume":"3","author":"Hage","year":"2011","journal-title":"Analytical Methods"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0200","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/jssc.200800640","article-title":"Characterization of drug-protein interactions in blood using high-performance affinity chromatography","volume":"32","author":"Hage","year":"2009","journal-title":"Journal of Separation Science"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0205","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.1021\/ac980734i","article-title":"Studies of protein binding to non-polar solutes by using zonal elution and high-performance affinity chromatography: Interactions of cis- and trans-clomiphene with human serum albumin in the presence of \u03b2-cyclodextrin","volume":"70","author":"Hage","year":"1998","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0210","series-title":"Handbook of affinity chromatography","article-title":"Application and elution in affinity chromatography","author":"Hage","year":"2006"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0215","series-title":"Biochemistry and biology of plasma lipoproteins","first-page":"403","article-title":"Lipoprotein structure","author":"Harmony","year":"1986"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0220","series-title":"The metabolic and molecular basis of inherited disease","first-page":"1129","article-title":"Structure and metabolism of plasma proteins","author":"Havel","year":"1995"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0225","series-title":"Immobilized affinity ligand techniques","first-page":"137","author":"Hermanson","year":"1992"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0230","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2165\/00003088-199426010-00004","article-title":"Drug binding in plasma: A summary of recent trends in the study of drug and hormone binding","volume":"26","author":"Herve","year":"1994","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0235","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/gut.51.3.398","article-title":"Overexpression of \u03b11-acid glycoprotein in transgenic mice leads to sensitization to acute colitis","volume":"51","author":"Hochepied","year":"2002","journal-title":"Gut"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0240","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1016\/S0021-9258(18)67052-8","article-title":"Nonenzymatic glycosylation of albumin in vivo. Identification of multiple glycosylated sites","volume":"261","author":"Iberg","year":"1986","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0245","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1081\/DMR-100104402","article-title":"Human alpha-1-glycoprotein and its interactions with drugs","volume":"33","author":"Israili","year":"2001","journal-title":"Drug Metabolism Reviews"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0250","doi-asserted-by":"crossref","first-page":"5833","DOI":"10.1007\/s00216-013-6981-3","article-title":"Use of entrapment and high-performance affinity chromatography to compare the binding of drugs and site-specific probes with normal and glycated human serum albumin","volume":"405","author":"Jackson","year":"2013","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ab.2010.05.004","article-title":"Entrapment of proteins in glycogen-capped and hydrazide-activated supports","volume":"404","author":"Jackson","year":"2010","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0260","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1021\/ac0483668","article-title":"Affinity monoliths for ultrafast immunoextraction","volume":"77","author":"Jiang","year":"2005","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0265","first-page":"591","article-title":"Kernicterus in rats with an inherited deficiency of glucuronyl transferase","volume":"97","author":"Johnson","year":"1959","journal-title":"American Journal of Diseases of Children"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0270","article-title":"Biochemistry of lipids, lipoproteins, and membranes","author":"Jonas","year":"2002"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0275","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.jpba.2010.09.003","article-title":"Binding of tolbutamide to glycated human serum albumin","volume":"54","author":"Joseph","year":"2011","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0280","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.jchromb.2010.08.021","article-title":"Chromatographic analysis of acetohexamide binding to glycated human serum albumin","volume":"878","author":"Joseph","year":"2010","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0285","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jpba.2010.04.035","article-title":"The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan","volume":"53","author":"Joseph","year":"2010","journal-title":"Journal of Pharmaceutical and Biomedical Analysis"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0290","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.jchromb.2010.04.019","article-title":"Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography","volume":"878","author":"Joseph","year":"2010","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0295","doi-asserted-by":"crossref","first-page":"3492","DOI":"10.1016\/j.chroma.2008.09.080","article-title":"Evaluation of alternatives to warfarin as probes for Sudlow site I of human serum albumin: Characterization by high-performance affinity chromatography","volume":"1216","author":"Joseph","year":"2009","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0300","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1021\/ac0700629","article-title":"Macroporous monolithic layers as efficient 3-D microarrays for quantitative detection of virus-like particles","volume":"79","author":"Kalashnikova","year":"2007","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0305","first-page":"494","article-title":"Effect on bilirubin metabolism in the newborn of sulfisoxazole administered to the mother","volume":"17","author":"Kantor","year":"1961","journal-title":"Obstetrics & Gynecology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jchromb.2004.11.006","article-title":"Chromatographic analysis of carbamazepine binding to human serum albumin","volume":"816","author":"Kim","year":"2005","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0315","series-title":"Handbook of affinity chromatography","article-title":"Immobilization methods for affinity chromatography","author":"Kim","year":"2006"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0320","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jchromb.2006.03.062","article-title":"Chromatographic analysis of carbamazepine binding to human serum albumin. II. Comparison of the Schiff base and N-hydroxysuccinimide immobilization methods","volume":"837","author":"Kim","year":"2006","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0325","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jchromb.2008.05.029","article-title":"Rapid analysis of the interactions between drugs and human serum albumin (HSA) using high-performance affinity chromatography (HPAC)","volume":"870","author":"Kim","year":"2008","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0330","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1002\/(SICI)1099-081X(199712)18:9<791::AID-BDD66>3.0.CO;2-1","article-title":"Effects of glycosylation of hypoglycemic drug binding to serum albumin","volume":"18","author":"Koyama","year":"1997","journal-title":"Biopharmaceuticals and Drug Disposition"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0335","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0006-2952(02)01074-2","article-title":"Predicting plasma protein binding of drugs: A new approach","volume":"64","author":"Kratochwil","year":"2002","journal-title":"Biochemical Pharmacology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)00015-8","article-title":"Drug binding to human alpha1-acid glycoprotein in health and disease","volume":"40","author":"Kremer","year":"1988","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0345","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1039\/B212850K","article-title":"Capillary electrophoretic study on pH dependence of enantioselective disopyramide binding to genetic variants of human \u03b11-acid glycoprotein","volume":"128","author":"Kuroda","year":"2003","journal-title":"Analyst"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0350","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1681\/ASN.2006091006","article-title":"Lipoprotein metabolism and lipid management in chronic kidney disease","volume":"18","author":"Kwan","year":"2007","journal-title":"Journal of the American Society of Nephrology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0355","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0009-8981(85)90082-8","article-title":"Free drug measurements: Methodology and clinical significance","volume":"151","author":"Kwong","year":"1985","journal-title":"Clinical Chimica Acta"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0360","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/jms.842","article-title":"Mass spectrometric study of in vivo production of advanced glycation end-products\/peptides","volume":"40","author":"Lapolla","year":"2005","journal-title":"Journal of Mass Spectrometry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0365","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1002\/mas.20090","article-title":"The role of mass spectrometry in the study of non-enzymatic protein glycation in diabetes: An update","volume":"25","author":"Lapolla","year":"2006","journal-title":"Mass Spectrometry Reviews"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0370","first-page":"141","article-title":"Plasma protein binding of drug\u2014Some basic and clinical aspects","volume":"10","author":"Lindup","year":"1987","journal-title":"Progress in Drug Metabolism"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0375","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0378-4347(92)80386-5","article-title":"Characterization of thyroxine-albumin binding using high-performance affinity chromatography. I. Interactions at the warfarin and indole sites of albumin","volume":"579","author":"Loun","year":"1992","journal-title":"Journal of Chromatography"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0380","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1021\/ac00093a043","article-title":"Chiral separation mechanisms in protein-based HPLC columns. I. Thermodynamic studies of (R)- and (S)- warfarin binding to immobilized human serum albumin","volume":"66","author":"Loun","year":"1994","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0385","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0378-4347(94)00547-I","article-title":"Characterization of thyroxine-albumin binding using high-performance affinity chromatography. II. Comparison of the binding of thyroxine, triiodothyronines and related compounds at the warfarin and indole sites of human serum albumin","volume":"665","author":"Loun","year":"1995","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0390","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0022-2275(20)34443-6","article-title":"Plasma lipoproteins: Apolipoprotein structure and function","volume":"25","author":"Mahley","year":"1984","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0395","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/jssc.200600152","article-title":"Affinity monolith chromatography","volume":"12","author":"Mallik","year":"2006","journal-title":"Journal of Separation Science"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0400","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1021\/ac061779j","article-title":"Development of sulfhydryl-reactive silica for protein immobilization in high-performance affinity chromatography","volume":"79","author":"Mallik","year":"2007","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0405","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ab.2008.01.035","article-title":"Immobilization of alpha1-acid glycoprotein for chromatographic studies of drug-protein binding II. Correction for errors in association constant measurements","volume":"376","author":"Mallik","year":"2008","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0410","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.chroma.2007.03.063","article-title":"Development of an affinity silica monolith containing \u03b11-acid glycoprotein for chiral separations","volume":"1149","author":"Mallik","year":"2007","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0415","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1016\/j.chroma.2010.02.026","article-title":"Analysis of drug\u2013protein binding by ultrafast affinity chromatography using immobilized human serum albumin","volume":"1217","author":"Mallik","year":"2010","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0420","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4939-2447-9_21","article-title":"Analysis of drug-protein interactions by high-performance affinity chromatography: Interactions of sulfonylurea drugs with normal and glycated human serum albumin","volume":"1286","author":"Matsuda","year":"2015","journal-title":"Methods in Molecular Biology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0425","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00216-011-5382-8","article-title":"High-performance affinity chromatography and that analysis of drug interactions with modified proteins: Binding of gliclazide with glycated human serum albumin","volume":"401","author":"Matsuda","year":"2011","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0430","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chroma.2012.09.091","article-title":"Analysis of drug interactions with modified proteins by high-performance affinity chromatography: Binding of glibenclamide to normal and glycated human serum albumin","volume":"1265","author":"Matsuda","year":"2012","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0435","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1515\/revac-2013-0029","article-title":"Studies of drug interactions with glycated human serum albumin by high-performance affinity chromatography","volume":"33","author":"Matsuda","year":"2014","journal-title":"Reviews in Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0440","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1007\/s00216-015-8688-0","article-title":"Analysis of glipizide binding to normal and glycated human serum albumin by high-performance affinity chromatography","volume":"407","author":"Matsuda","year":"2015","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0445","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.chroma.2015.07.012","article-title":"Analysis of multi-site drug-protein interactions by high-performance affinity chromatography: Binding by glimepiride to normal or glycated human serum albumin","volume":"1408","author":"Matsuda","year":"2015","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(90)90177-K","article-title":"Lipoprotein(a): Structure, properties, and possible involvement in thrombogenesis and atherogenesis","volume":"85","author":"Mbewu","year":"1990","journal-title":"Atherosclerosis"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0455","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.abb.2005.10.019","article-title":"The effect of non-enzymatic glycation on the unfolding of human serum albumin","volume":"444","author":"Mendez","year":"2005","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0460","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jchromb.2003.10.054","article-title":"Development and characterization of an open tubular column containing immobilized P-glycoprotein for rapid on-line screening for P-glycoprotein substrates","volume":"799","author":"Moaddel","year":"2004","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0465","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S1357-2725(02)00031-6","article-title":"Thermodynamic analysis of human serum albumin interactions with glucose: Insights into the diabetic range of glucose concentration","volume":"34","author":"Mohamadi-Nejad","year":"2002","journal-title":"The International Journal of Biochemistry & Cell Biology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0470","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-9673(01)94662-X","article-title":"Peak-decay method for the measurement of dissociation rate constants by high-performance affinity chromatography","volume":"384","author":"Moore","year":"1987","journal-title":"Journal of Chromatography"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0475","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev.bi.44.070175.001151","article-title":"Lipoproteins: Structure and function","volume":"44","author":"Morrisett","year":"1975","journal-title":"Annual Review of Biochemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0480","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbagen.2003.08.001","article-title":"The effect of glycation on the structure, function and biological fate of human serum albumin as revealed by recombinant mutants","volume":"1623","author":"Nakajou","year":"2003","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0485","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jacc.2010.01.008","article-title":"High-density lipoprotein and coronary heart disease: Current and future therapies","volume":"55","author":"Natarajan","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0490","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jchromb.2009.04.004","article-title":"Biointeraction analysis by high-performance affinity chromatography: Kinetic studies of immobilized antibodies","volume":"878","author":"Nelson","year":"2010","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0495","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0378-4347(92)80252-L","article-title":"Allosteric and competitive displacement of drugs from human serum albumin by octanoic acid, as revealed by high-performance liquid affinity chromatography on a human serum albumin-based stationary phase","volume":"577","author":"Noctor","year":"1992","journal-title":"Journal of Chromatography"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0500","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1172\/JCI103864","article-title":"Studies in kernicterus. I. The protein binding of bilirubin","volume":"38","author":"Odell","year":"1959","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0505","doi-asserted-by":"crossref","first-page":"7547","DOI":"10.1021\/ac061215f","article-title":"Analysis of free drug fractions using near-infrared fluorescent labels and an ultrafast immunoextraction\/displacement assay","volume":"78","author":"Ohnmacht","year":"2006","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0510","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2133\/dmpk.20.309","article-title":"A molecular functional study on the interactions of drugs with plasma proteins","volume":"20","author":"Otagiri","year":"2005","journal-title":"Drug Metabolism and Pharmacokinetics"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0515","series-title":"Handbook of affinity chromatography","first-page":"663","article-title":"Chromatographic studies of molecular recognition and solute binding to enzymes and plasma proteins","author":"Patel","year":"2006"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0520","series-title":"All about albumin: Biochemistry, genetics, and medical applications","author":"Peters","year":"1996"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0525","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ymeth.2011.08.016","article-title":"Biointeraction analysis of immobilized antibodies and related agents by high-performance immunoaffinity chromatography","volume":"56","author":"Pfaunmiller","year":"2012","journal-title":"Methods"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0530","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0021-9673(99)00672-X","article-title":"Quantitative fast fractionation of a pool of polyclonal antibodies by immunoaffinity memebrane chromatography","volume":"852","author":"Plantonova","year":"1999","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0535","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0021-9673(94)80332-3","article-title":"Development of dihydrazide-activated silica supports for high-performance affinity chromatography","volume":"669","author":"Ruhn","year":"1994","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0540","first-page":"477","article-title":"Stereoselective serum protein binding of ketoprofen in liver disease","volume":"4","author":"Sakai","year":"1999","journal-title":"Enantiomer"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0545","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1002\/jssc.200800685","article-title":"Kinetic studies of biological interactions by affinity chromatography","volume":"32","author":"Schiel","year":"2009","journal-title":"Journal of Separation Science"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0550","doi-asserted-by":"crossref","first-page":"9384","DOI":"10.1021\/ac201973v","article-title":"Development of a flow-based ultrafast immunoextraction and reverse displacement immunoassay: Analysis of free drug fractions","volume":"83","author":"Schiel","year":"2011","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0555","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0005-2795(77)90080-0","article-title":"The carbohydrate unites of human plasma \u03b11-acid glycoprotein","volume":"492","author":"Schmid","year":"1977","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0560","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jmb.2008.09.020","article-title":"The 1.8-\u00c5 crystal structure \u03b11-acid glycoprotein (orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin","volume":"384","author":"Schonfeld","year":"2008","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0565","doi-asserted-by":"crossref","first-page":"440A","DOI":"10.1021\/ac041684m","article-title":"Biosensor alternative: Frontal affinity chromatography","volume":"76","author":"Schriemer","year":"2004","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0570","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/bio.2494","article-title":"Competitive binding of fluoroquinolone antibiotics and some other drugs to human serum albumin: A luminescence spectroscopic study","volume":"28","author":"Seedher","year":"2013","journal-title":"Luminescence"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0575","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1747-0285.2008.00704.x","article-title":"Reversible binding of antidiabetic drugs, repaglinide and gliclazide, with human serum albumin","volume":"72","author":"Seedher","year":"2008","journal-title":"Chemical Biology & Drug Design"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0580","first-page":"107","article-title":"Fluorescence spectroscopic study for competitive binding of antidiabetic drugs and endogenous substances on serum albumin","volume":"28","author":"Seedher","year":"2013","journal-title":"Drug Metabolism and Personalized Therapy"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0585","first-page":"91","article-title":"Characterization of the binding of digitoxin and acetyldigitoxin to human serum albumin by high-performance affinity chromatography","volume":"725","author":"Sengupta","year":"1999","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0590","doi-asserted-by":"crossref","first-page":"3821","DOI":"10.1021\/ac9903499","article-title":"Characterization of minor site probes for human serum albumin by high-performance affinity chromatography","volume":"71","author":"Sengupta","year":"1999","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0595","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jmb.2006.06.028","article-title":"Location of high and low affinity fatty acid binding sites on human serum albumin revealed by NMR drug-competition analysis","volume":"361","author":"Simard","year":"2006","journal-title":"Journal of Molecular Biology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0600","series-title":"Blood lipids and lipoproteins: Quantitation, composition, and metabolism","first-page":"471","article-title":"Plasma lipoproteins: composition, structure and biochemistry","author":"Skipski","year":"1972"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0605","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00216-012-5816-y","article-title":"Identification and analysis of stereoselective drug interactions with low-density lipoprotein by high-performance affinity chromatography","volume":"403","author":"Sobansky","year":"2012","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0610","article-title":"Analysis of drug interactions with lipoproteins by high-performance affinity chromatography","volume":"Vol. 53","author":"Sobansky","year":"2012"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0615","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1007\/s00216-014-8081-4","article-title":"Analysis of drug interactions with very low density lipoprotein by high-performance affinity chromatography","volume":"406","author":"Sobansky","year":"2014","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0620","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.jchromb.2010.01.016","article-title":"Analysis of lidocaine interactions with serum proteins using high-performance affinity chromatography","volume":"878","author":"Soman","year":"2010","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0625","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-2275(20)36723-7","article-title":"Fatty acid binding to plasma albumin","volume":"16","author":"Spector","year":"1976","journal-title":"Journal of Lipid Research"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0630","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0026-895X(25)10691-3","article-title":"The characterization of two specific drug binding sites on human serum albumin","volume":"11","author":"Sudlow","year":"1975","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0635","series-title":"Textbook of clinical chemistry","author":"Tietz","year":"1986"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0640","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/nrd2251","article-title":"Stratified medicine strategic and economic implications of combining drugs and clinical biomarkers","volume":"6","author":"Trusheim","year":"2007","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0645","doi-asserted-by":"crossref","first-page":"4790","DOI":"10.1021\/ac970565m","article-title":"Effects of ligand heterogeneity in the characterization of affinity columns by frontal analysis","volume":"69","author":"Tweed","year":"1997","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0650","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF00731324","article-title":"Alpha1-acid glycoprotein (orosomucoid): Pathophysiological changes in glycosylation in relation to its function","volume":"12","author":"Van Dijk","year":"1995","journal-title":"Glycoconjugate Journal"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0655","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-4347(92)80120-F","article-title":"Effect of glycation on the heterogeneity of human serum albumin analysed by reversed-phase high-performance liquid chromatography in a solvent containing formic acid","volume":"573","author":"Vidal","year":"1992","journal-title":"Journal of Chromatography"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0660","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s00216-010-3737-1","article-title":"Drug\u2013protein binding: A critical review of analytical tools","volume":"398","author":"Vuignier","year":"2010","journal-title":"Analytical and Bioanalytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0665","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cca.2007.06.011","article-title":"Characterization of glycation adducts on human serum albumin by matrix-assisted laser desorption\/ionization time-of-flight","volume":"385","author":"Wa","year":"2007","journal-title":"Clinica Chimica Acta"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0670","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ab.2005.11.015","article-title":"Obtaining high sequence coverage in matrix-assisted laser desorption time-of-flight mass spectrometry for studies of protein modification: Analysis of human serum albumin as a model","volume":"349","author":"Wa","year":"2006","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0675","series-title":"Analytical affinity chromatography","first-page":"117","article-title":"Practical approaches for the measurement of rate constants by affinity chromatography","author":"Walters","year":"1987"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0680","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.colsurfb.2008.03.008","article-title":"Spectroscopic investigation on the binding of bioactive pyridazinone derivative to human serum albumin and molecular modeling","volume":"65","author":"Wang","year":"2008","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0685","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/js970407a","article-title":"Role of plasma lipoproteins in modifying the biological activity of hydrophobic drugs","volume":"87","author":"Wasan","year":"1998","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0690","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ab.2005.08.025","article-title":"Immobilization of alpha1-acid glycoprotein for chromatographic studies of drug-protein binding","volume":"346","author":"Xuan","year":"2005","journal-title":"Analytical Biochemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0695","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1002\/jssc.201000214","article-title":"Biointeraction analysis of carbamazepine binding to alpha1-acid glycoprotein by high-performance affinity chromatography","volume":"33","author":"Xuan","year":"2010","journal-title":"Journal of Separation Science"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0700","series-title":"Monolithic chromatography and its modern applications","first-page":"3","article-title":"Affinity monolith chromatography: principles and recent developments","author":"Yoo","year":"2010"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0705","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.chroma.2010.09.070","article-title":"Use of peak decay analysis and affinity microcolumns containing silica monoliths for rapid determination of drug-protein dissociation rates","volume":"1218","author":"Yoo","year":"2011","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0710","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1002\/jssc.201100280","article-title":"High-throughput analysis of drug dissociation from serum proteins using affinity silica monoliths","volume":"34","author":"Yoo","year":"2011","journal-title":"Journal of Separation Science"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0715","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jchromb.2010.04.028","article-title":"Evaluation of affinity microcolumns containing human serum albumin for rapid analysis of drug-protein binding","volume":"878","author":"Yoo","year":"2010","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0720","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.jchromb.2009.02.070","article-title":"Studies of imipramine binding to human serum albumin by high-performance affinity chromatography","volume":"877","author":"Yoo","year":"2009","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0725","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.chroma.2006.12.081","article-title":"Sequential injection affinity chromatography utilizing an albumin immobilized monolithic column to study drug-protein interactions","volume":"1144","author":"Zacharis","year":"2006","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0730","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1651-2227.1971.tb06615.x","article-title":"Separation by gel filtration and microdetermination of unbound bilirubin. II. Study of sera in icteric newborn infants","volume":"60","author":"Zamet","year":"1971","journal-title":"Acta Paediatrica"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0735","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1021\/pr800858h","article-title":"A perspective on the Maillard reaction and the analysis of protein glycation by mass spectrometry: Probing the pathogenesis of chronic disease","volume":"8","author":"Zhang","year":"2009","journal-title":"Journal of Proteome Research"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0740","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jchromb.2014.01.026","article-title":"Analysis of biomolecular interactions using affinity microcolumns: A review","volume":"968","author":"Zheng","year":"2014","journal-title":"Journal of Chromatography B"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0745","doi-asserted-by":"crossref","first-page":"6454","DOI":"10.1021\/ac501031y","article-title":"Determination of rate constants and equilibrium constants for solution-phase drug-protein interactions by ultrafast affinity extraction","volume":"86","author":"Zheng","year":"2014","journal-title":"Analytical Chemistry"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0750","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chroma.2014.10.092","article-title":"Analysis of free drug fractions by ultrafast affinity extraction: Interactions of sulfonylurea drugs with normal or glycated human serum albumin","volume":"1371","author":"Zheng","year":"2014","journal-title":"Journal of Chromatography A"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0755","doi-asserted-by":"crossref","first-page":"6262","DOI":"10.1039\/c3an01315d","article-title":"Analysis of free fractions for chiral drugs using ultrafast extraction and multi-dimensional high-performance affinity chromatography","volume":"138","author":"Zheng","year":"2013","journal-title":"Analyst"},{"key":"10.1016\/bs.apcsb.2015.09.007_bb0760","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1007\/s00439-012-1188-9","article-title":"Personalized medicine using DNA biomarkers: A review","volume":"131","author":"Ziegler","year":"2012","journal-title":"Human Genetics"}],"container-title":["Advances in Protein Chemistry and Structural Biology","Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187616231500070X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187616231500070X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T09:09:29Z","timestamp":1748682569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187616231500070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9780128047958"],"references-count":152,"URL":"https:\/\/doi.org\/10.1016\/bs.apcsb.2015.09.007","relation":{},"ISSN":["1876-1623"],"issn-type":[{"value":"1876-1623","type":"print"}],"subject":[],"published":{"date-parts":[[2016]]}}}